Clinical Trials in New York

Showing 18161-18180 of 22,668 trials

LEGION™ Revision Metal Hypersensitivity Study

NCT02412813

This is a prospective, randomized, multi-center, metal hypersensitivity study comparing OXINIUM and cobalt chrome femoral components in subjects with failed total knee arthroplasty (TKA).

Total Knee Replacement Revision

Smith & Nephew, Inc.Started Jan 2016

Egg Harbor, New Jersey, United States • New York, New York, United States • Winnipeg, Manitoba, Canada

COMPLETEDNA< 1 mile

ProspEctive First Evaluation in Chest Pain Trial

NCT01604655

The purpose of this study is to determine the best initial test in patients admitted to the hospital complaining of chest pain.

Chest PainShortness of BreathSuspected Acute Coronary Syndrome

St. Luke's-Roosevelt Hospital Center411 participantsStarted Sep 2011

New York, New York, United States

COMPLETEDPhase 3< 1 mile

Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease

NCT00434148

This study will evaluate the safety and efficacy of two different doses of Pasireotide in patients with de novo or recurrent/persistent Cushing's Disease.

Cushing's Disease

Novartis Pharmaceuticals162 participantsStarted Dec 2006

Stanford, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +65 more locations

LEGION™ Revision Metal Hypersensitivity Study

ProspEctive First Evaluation in Chest Pain Trial

Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease

Find Trials by Condition in New York

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Women With Epilepsy: Pregnancy Outcomes and Deliveries

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.

Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Effect of Vocal Exercise After Botulinum Toxin Injection for Spasmodic Dysphonia

Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel

A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients

Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties

Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

ProMRI PROVEN Master Study

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients